Subscription Required

Only paid subscribers* to Specialty Pharmacy News can access this Web portal with three years of back issues, searchable article archives and other valuable resources.

Subscribers to Specialty Pharmacy News receive

  • 12 monthly issues packed with news and strategies on this increasingly vital sector in health business, delivered First Class by U.S. Mail and electronically (optional),
  • E-News Alerts whenever important news breaks, and
  • Access to a subscriber-only Web page with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Recent stories of interest grouped for convenient reading
    • Bonus reports for subscribers, and
    • Regular postings from your editor.
View a sample and get more information
March 2017

Recent Stories

From Specialty Pharmacy News - Harvard Pilgrim Health Care, Inc. continues to add to its value-based arrangements with new deals for two specialty drugs. The insurer said Feb. 22 it had signed outcomes-based contracts with Amgen Inc. for its anti-inflammatory treatment Enbrel (etanercept) and Eli Lilly and Co. for its osteoporosis medication Forteo (teriparatide). As costs for specialty drugs in particular continue to rise, payers are looking beyond traditional management tactics to keep spending in check. And pharmaceutical manufacturers — increasingly under fire for rising drug prices — are seeking ways to demonstrate their medications’ value. Contracts such as these can tick both these boxes. Read more

In an effort to improve the care it provides to people with… Read more

The FDA is standing firm in its preference for using four-letter suffixes… Read more

With the amount of reported direct and indirect remuneration (DIR) in Medicare… Read more

From the Editor

Welcome to your Specialty Pharmacy News subscriber-only Web page

Be sure to visit often, for PDFs of issues, archives of articles and data, and more!

Please e-mail me with your comments on the last issue of Specialty Pharmacy News, story ideas for future issues, or any other suggestions you have that can make the newsletter more useful for you.

March 22, 2017
Bonus Insight Reports for Subscribers

Several special reports covering key areas of concern to today’s health care executives are now available in your Subscriber Library. These original reports from the AIS Health editorial team are filled with business insights and practical advice on the pharmacy issues that affect payers and providers the most. Access them at

January 17, 2017
Long-Awaited Biosimilar Interchangeability Draft Guidance Is Out

FDA finally unveils interchangeability draft guidance for biosimilars, expects “that applications generally will include data from a switching study or studies in one or more appropriate conditions of use,” among other criteria

January 12, 2017
FDA Finalizes Naming Guidance for Biologics, Biosimilars

In final guidance, FDA says all biologics, not only biosimilars, will have four-letter suffixes; agency still considering “appropriate suffix format” for interchangeable biosimilars

It's quick and easy to sign up for FREE access to!

Why do I need to register?